MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-04-0033700
Parastin Pharma Private Limited
Parastin Pharma Private Limited - business services in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹69.97 Lakh
▼ 3% YoY
Net profit · FY 2025
₹2.93 Lakh
Net margin 4.2%
EBITDA · FY 2025
₹3.92 Lakh
EBITDA margin 5.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Parastin Pharma Private Limited
Data last updated:
Parastin Pharma Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 16 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2020PTC351992. Its GSTIN is 27AALCP7066K1ZR (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Yogesh Hiralal Kshirsagar and Sandip Supadu Mali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot.No. 20 Survey.No. 219/1 – B Tirupati.Hou.Soc, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2025, the company reported a revenue of ₹69.97 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.93 Lakh (net margin 4.2%) and EBITDA of ₹3.92 Lakh (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years.
Parastin Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0033700).
Company details
CIN U74999MH2020PTC351992
Registration Number 351992
Incorporation Date 16 December 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0033700
Key People
Yogesh Hiralal Kshirsagar Director Sandip Supadu Mali Director Uttam Bhagwan Mali Additional Director Recognitions & Rankings of Parastin Pharma
Contact details
Parastin Pharma Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot.No. 20 Survey.No. 219/1 – B Tirupati.Hou.Soc, Aurangabad, Maharashtra, India – 431001
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Parastin Pharma Private Limited, buy the company report.
Comprehensive company report
Parastin Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Parastin Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Parastin Pharma Private Limited, buy the company report.
Financials of Parastin Pharma Private Limited
FY 2025 filings availableParastin Pharma Private Limited reported revenue of ₹69.97 Lakh (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹69.97 Lakh ▼ 3%
Net profit · FY 2025
₹2.93 Lakh margin 4.2%
EBITDA · FY 2025
₹3.92 Lakh margin 5.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 62%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 629%
Revenue fell 3% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 62%. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.93 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Parastin Pharma Private Limited, buy the company report.
Board of directors of Parastin Pharma Private Limited
Parastin Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yogesh Hiralal Kshirsagar | Director | 16 Dec 2020 | 5 Years 10 Months | Current |
| Sandip Supadu Mali | Director | 16 Dec 2020 | 5 Years 10 Months | Current |
| Uttam Bhagwan Mali | Additional Director | 06 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
Parastin Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arekal Organics & Bio Fertilizers Private Limited | ₹70.16 Lakh (FY 2024) | 18.0% | Bangalore, Karnataka, India | |||
| Sunwell Organics Private Limited | ₹70.13 Lakh (FY 2019) | 6875.0% | Dist:Bharucu, Gujarat, India | |||
| Mahaoxy India Private Limited | ₹70.07 Lakh (FY 2024) | -12.0% | Nipani, Karnataka, India | |||
| Bhagwat Industries Private Limited | ₹70.05 Lakh (FY 2024) | -30.0% | Jaipur, Rajasthan, India | |||
| Hemas Consumer Brands India Private Limited | ₹69.98 Lakh (FY 2025) | -74.0% | Kolkata, West Bengal, India | |||
| Parastin Pharma Private Limitedthis company | ₹69.97 Lakh (FY 2025) | ₹2.93 Lakh | 4.2% | -3.0% | Aurangabad, Maharashtra, India | |
| Perseverance Industries India Private Limited | ₹69.96 Lakh (FY 2024) | Pune, Maharashtra, India | ||||
| Arora Soap and Detergents Private Limited | ₹69.91 Lakh (FY 2025) | 4.0% | Delhi, India | |||
| Medispice Herbals Private Limited | ₹69.91 Lakh (FY 2025) | -34.0% | New Delhi, Delhi, India | |||
| Karveer Meditech Private Limited | ₹69.86 Lakh (FY 2025) | -62.0% | Kolhapur, Maharashtra, India | |||
| Kalindi Chemicals Private Limited | ₹69.82 Lakh (FY 2024) | -46.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Parastin Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Parastin Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Parastin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Parastin Pharma Private Limited has 1 active EPFO establishment as of Apr 01, 2024.
Active EPFO establishments
1
GST
Parastin Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCP7066K1ZR | Maharashtra | Active | 19 Feb 2021 |
To see the full GST registrations and return filing status of Parastin Pharma Private Limited, buy the company report.
Recent activity
Parastin Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Uttam Bhagwan Mali was appointed as Additional Director on 06 Dec 2021.
AGM
Parastin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Parastin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Uttam Bhagwan Mali was appointed as Additional Director.
Appointed
Sandip Supadu Mali was appointed as Director.
Appointed
Yogesh Hiralal Kshirsagar was appointed as Director.
Incorporation
16 Dec 2020
Parastin Pharma Private Limited was registered on 16 Dec 2020 with Roc Mumbai Ii & aged 5 years 10 months as per MCA records.
Frequently asked questions
Parastin Pharma is an active private limited company based in Aurangabad, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 16 December 2020 (6+ years old) and is registered under CIN U74999MH2020PTC351992.
Parastin Pharma has 3 current directors:
- Yogesh Hiralal Kshirsagar - Director
- Sandip Supadu Mali - Director
- Uttam Bhagwan Mali - Additional Director
The latest financial statements of Parastin Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Parastin Pharma is 27AALCP7066K1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Parastin Pharma is U74999MH2020PTC351992. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parastin Pharma was incorporated on 16 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Parastin Pharma by revenue are Arekal Organics & Bio Fertilizers Private Limited, Sunwell Organics Private Limited, Mahaoxy India Private Limited, Bhagwat Industries Private Limited, Hemas Consumer Brands India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Uttam Bhagwan Mali was appointed as Additional Director on 06 Dec 2021. Sandip Supadu Mali was appointed as Director on 16 Dec 2020. Yogesh Hiralal Kshirsagar was appointed as Director on 16 Dec 2020.
Yes, Parastin Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0033700).
The registered office of Parastin Pharma is at Plot.No. 20 Survey.No. 2191 – B Tirupati.Hou.Soc, Aurangabad, Maharashtra, India – 431001.
Parastin Pharma operates in the business services industry, in the other services segment.